TechCrunch

MARCH 17, 2023

Best practices for leveraging artificial intelligence and machine learning in 2023 Zero-based budgeting: A proven framework for extending runway Image Credits: Getty Images It’s critical to make every dollar count in this environment, but pulling back too much in the wrong places can reduce momentum across your entire organization. “The

Budget 230

Budget Biotech Artificial Inteligence Banking 230

Crunchbase News

FEBRUARY 16, 2024

Not exactly sure what was in the water this week, but AI and biotech led the way as happens often. Lambda , $320M, artificial intelligence: In a big week, this was the biggest round. The company offers cloud computing services and hardware for training artificial intelligence software. billion valuation.

Lambda 93

Lambda Biotech Artificial Intelligence Artificial Inteligence 93

CIO

MAY 15, 2024

The biotech company Moderna , for example, is aiming to use ChatGPT Enterprise to “automate nearly every business process” in order to “outpace its plan to roll out 15 new products within the next five years.” And with every passing day, “your guess is as good as mine” will become an increasingly uncomfortable answer.

Artificial Inteligence 322

Artificial Inteligence Generative AI Biotech Artificial Intelligence 322

Crunchbase News

MARCH 29, 2024

While there were no huge rounds like last week, money was again spread around from AI to biotech to marketing and more. Celestial AI , $175M, semiconductors: Optical interconnectivity startup Celestial AI raised a massive $175 million Series C led by Thomas Tull ’s US Innovative Technology Fund.

Biotech 105

Biotech Artificial Intelligence Artificial Inteligence Energy 105

Crunchbase News

APRIL 19, 2024

Metsera , $290M, biotech: This week was a slower week than normal for biotech — as it was for most sectors — but that didn’t stop New York-based Metsera. The company develops power-optimized chips targeting the data analytics and generative AI markets. In fact, it only took raising about $30 million-plus to make the list.

Biotech 105

Biotech Generative AI Artificial Intelligence Artificial Inteligence 105

Crunchbase News

JUNE 28, 2024

Formation Bio , $372M, biotech: Every week there is a big biotech raise and this week’s is really big. More and more biotech startups are using AI to help with their drug processes and investors are clearly taking note. Sidecar Health believes a free-market approach will ensure healthcare is more accessible and affordable.

Artificial Inteligence 86

Artificial Inteligence Biotech Generative AI Healthcare 86

CIO

APRIL 17, 2024

Normally, a CCO develops ideas about what the market needs and communicates them to a design team, which produces sketches to then be reviewed by the CCO. As the technology exhausts its honeymoon period, and companies in all industries find new ways of using it to get ahead of the competition, a new race is on.

Software Review 321

Software Review Enterprise Generative AI Artificial Inteligence 321

Crunchbase News

MAY 2, 2024

April also saw a half-dozen rounds of a quarter-billion dollars or more, including a $1 billion round for an AI-enhanced biotech. Xaira Therapeutics , $1B, biotech: The biggest round in April was really big. The company develops power-optimized chips targeting the data analytics and generative AI markets. Let’s take a look.

Biotech 111

Biotech Blockchain Generative AI Energy 111

Crunchbase News

JULY 2, 2024

Clearly GM is betting — big — the autonomous driving and robotaxi market comes back. AlphaSense , $650M, artificial intelligence: AI-driven market intelligence platform AlphaSense raised $650 million in funding co-led by Viking Global Investors and BDT & MSD Partners at a $4 billion valuation — a 75% increase from just nine months ago.

Artificial Inteligence 93

Artificial Inteligence Biotech Software Review Healthcare 93

Crunchbase News

JULY 9, 2024

And there are signs that larger M&A deals increased in Q2, providing much-needed liquidity to venture capital markets. While this past quarter was amongst the highest for funding since Q1 2023, it is not necessarily a signal of a venture market comeback. Healthcare and biotech was the second-largest sector, raising $17 billion.

Biotech 118

Biotech Report Software Review Technical Review 118

Crunchbase News

AUGUST 1, 2024

While we saw a lot of the regular sectors like biotech and financial services represented, we also saw some big deals involving supply chain and automotive startups. Element Biosciences , $277M, biotech: Every month there seems to be big biotech raises, and this one’s no different.

Biotech 91

Biotech Automotive Pharmaceuticals Healthcare 91

Crunchbase News

FEBRUARY 15, 2024

The venture market was down 38% last year as investors continued to reel back their funding with money becoming more expensive and liquidity options drying up. With its cash-intensive research and long product-to-market lead time, it usually is not attractive to investors in a down market where cash is king.

Biotech 95

Biotech Artificial Intelligence Artificial Inteligence Energy 95

TechCrunch

DECEMBER 2, 2020

Sifting through the trillions of molecules out there that might have powerful medicinal effects is a daunting task, but the solution biotech has found is to work smarter, not harder. Machine learning has, of course, accelerated work in many fields, biochemistry among them, but he felt that the potential of the technology had not been tapped.

Biotech 265

Biotech 3D Artificial Inteligence Machine Learning 265

TechCrunch

MARCH 16, 2023

Charge it : Parker is taking on the world of corporate cards — and trying to grab a piece of the market from companies like Brex and Ramp — with its new credit offering tailored to the needs of e-commerce brands. Staying power : 5 strategies for biotech startups to outlast a market downturn , as advised by James Coates.

Banking 249

Banking Biotech Report Artificial Intelligence 249

TechCrunch

SEPTEMBER 28, 2021

Lifebit says it has a patented technology for federating the data around genomic data, allowing researchers to get more insights while keeping the data secure. In an increasingly hot biotech market, protecting IP is key. Privacy issues are regularly raised around genomic data.

Biotech 248

Biotech Data Government Research 248

TechCrunch

SEPTEMBER 14, 2021

Other fungicides on the market today require seven days before re-entry and pre-harvest, Uknes explained. His firm has an impact fund focused on the future of food and began investing in alternative proteins in 2016 before expanding that to delivery systems in agriculture technology, he said.

Technical Review 235

Technical Review Technology Chemicals Pharmaceuticals 235

Crunchbase News

FEBRUARY 7, 2024

While it’s too early to say venture funding will again increase in the sector this year, it is evident investors see the potential in both quantum technology and its ability to produce big financial returns. Kore.ai , $150M, artificial intelligence: Of course there’s a big round for a generative AI startup.

Energy 78

Energy Biotech Artificial Intelligence Artificial Inteligence 78

Crunchbase News

JANUARY 8, 2024

Table of contents Adieu, Q4 Late stage and technology growth Early stage Seed stage Exits M&A IPOs The big picture Methodology Glossary of funding terms Adieu, Q4 The fourth quarter of 2023 was particularly weak in comparison to recent prior quarters. For the fourth quarter, the largest early-stage rounds hailed from the biotech space.

Biotech 96

Biotech Generative AI Insurance Artificial Intelligence 96

Crunchbase News

MAY 6, 2024

This has been particularly true for companies that took the SPAC route to public markets around the peak of the last boom. In response, a growing number are choosing to exit public markets and try their luck once again as private companies. After debuting on Nasdaq in 2021 at a $2.1 It didn’t go well.

Biotech 109

Biotech Case Study Marketing Study 109

TechCrunch

NOVEMBER 23, 2022

compared to the same time last year, it’s even more important for emerging technologies to present more than promises. The influx of artificial intelligence in healthcare is exciting but often met with skepticism from the public, and rightfully so. Now, as venture capital funding within health tech has fallen 41.2%

How To 228

How To Healthcare Artificial Intelligence Artificial Inteligence 228

Crunchbase News

JUNE 27, 2024

Developers of workplace robots, robotic surgery technologies, and even humanoid models have all raised large rounds in the past six months. The artificial intelligence funding boom has also helped boost the space, with investors backing big deals at the intersection of AI and robotics. The challenge is all about execution.

Artificial Intelligence 129

Artificial Intelligence Artificial Inteligence Construction Healthcare 129

Crunchbase News

MAY 7, 2024

The slowdown in venture funding has continued despite the AI technology wave that has washed over startups in the past few years. Top sectors Biotech and healthcare was the leading sector by funding amount in April. That is an increase over 2023, but still too few companies to suggest the public markets are truly opening.

Biotech 119

Biotech Generative AI Report Healthcare 119

Crunchbase News

FEBRUARY 16, 2024

Hundreds of professional futurists now work in government, academia and other sectors, analyzing demographic, technological and climatic trends to envision what life will look like years from now. AI-enabled healthcare There’s a lot of funding for nascent companies at the intersection of artificial intelligence and healthcare.

Construction 112

Construction Artificial Intelligence Artificial Inteligence Generative AI 112

Crunchbase News

FEBRUARY 8, 2024

Last week AI private market investors likely rejoiced when it was reported data center startup Astera Labs was preparing for a potential March initial public offering. When Astera raised its massive round in 2022, the market for funding for U.S.-based Also, not every chip designer startup is focused on the AI market.

Artificial Intelligence 86

Artificial Intelligence Artificial Inteligence Software Review Systems Review 86

TechCrunch

SEPTEMBER 8, 2022

The startup is building a platform using synthetic DNA to store digital data, and has teamed up with storage vendor Seagate Technology for a research collaboration to advance its automated DNA storage and computation platform. Catalog , a Boston-based startup, has come up with a novel way of solving the problem.

Storage 206

Storage Artificial Inteligence Data Chemicals 206

Perficient

MAY 21, 2024

An inefficient system wastes time and resources, can diminish morale, and ultimately hinders efforts to bring life-saving drugs to market.

Pharmaceuticals 52

Pharmaceuticals Artificial Inteligence Data Systems Review 52

TechCrunch

FEBRUARY 22, 2022

The world’s labs are under pressure to do more tests and process more materials, not just due to COVID but from the growing biotech and drug development sectors — and automation is the sure path forwards. and wider European markets. the discovery and cultivation of purpose-built microbes).

Hardware 216

Hardware Biotech Technical Review Systems Review 216

TechCrunch

NOVEMBER 18, 2021

Therapeutic proteins, particularly monoclonal antibodies, are making up a bigger and bigger share of the drug market. Generate Biomedicines is focused on all protein modalities, but they have initially focused on developing antibodies, which Nally says make up about 60% of the protein-based biotherapeutics market. .

Artificial Inteligence 211

Artificial Inteligence Artificial Intelligence Machine Learning Report 211

TechCrunch

JANUARY 25, 2022

So, providing an intelligent system — which is one of InstaDeep’s applications — that can optimize train traffic, and manage constraints better, is highly marketable. But if technology has taught us anything, location doesn’t pose a barrier in getting global customers.

Enterprise 246

Enterprise Artificial Inteligence Machine Learning Transportation 246

Crunchbase News

JUNE 6, 2024

That year saw healthcare and biotech as the leading sector, with $20 billion invested in companies with a female founder. Female-only flat Funding amounts to female-only founded companies grew and contracted with the market changes in recent years. In 2021, close to $48 billion was invested — marking 14% of U.S.

Technical Review 121

Technical Review Biotech Trends Report 121

Existek

SEPTEMBER 28, 2023

With the major progress in all sub-domains of artificial intelligence, the demand for AI developers has tremendously increased. AI-related skills are highly valued in the market and adopted in various industries. Considering the rapid pace of technological advancements, we can’t underestimate the maturation of AI.

Artificial Inteligence 52

Artificial Inteligence Development How To Technical Review 52

TechCrunch

JANUARY 16, 2023

Late last week, in a rare sit-down before a small audience , this editor spent an hour with Sam Altman, the former president of Y Combinator and, since 2019, the CEO of OpenAI , the company he famously co-founded with Elon Musk and numerous others in 2015 to develop artificial intelligence for the “benefit of humanity.”

Energy 275

Energy Artificial Intelligence Artificial Inteligence ChatGPT 275

TechCrunch

MAY 18, 2021

Sold as aLab Suite , Artificial’s technology can both orchestrate and manage robotic machines that labs might be using to handle some work; and help assist scientists when they are carrying out the work themselves. “We view that as a central thesis that differentiates us from classic automation.”

Artificial Intelligence 246

Artificial Intelligence Artificial Inteligence Hardware Automotive 246

Crunchbase News

DECEMBER 15, 2023

The week was especially good for biotech, which led the way with two big raises. Tome Biosciences , $213M, biotech: A big biotech raise hit high on the list this week. Bicara Therapeutics , $165M, biotech: If Bicara Therapeutics looks familiar, it’s because this isn’t its first time on this list.

Biotech 96

Biotech Artificial Intelligence Artificial Inteligence Hotels 96

TechCrunch

SEPTEMBER 16, 2021

The total addressable market for language intelligence is big — Das estimated it to be $42 billion just for the life sciences sector. It will also put some funds into Sorcero’s go-to-market strategy to go after other use cases. The company will invest in talent in both engineering and on the commercial side.

Technical Review 222

Technical Review Pharmaceuticals Healthcare Policies 222

TechCrunch

JUNE 22, 2022

Friction created by prolonged implementation cycles, lack of adequate clinician involvement and difficult to measure ROI has left us with a healthcare system skeptical of technology. Automation is the key to a more resilient and efficient healthcare system, but increasing meaningful adoption remains challenging.

Healthcare 231

Healthcare Metrics Banking System 231

Crunchbase News

MAY 8, 2024

Starry : Boston-based Starry, an internet service provider and developer of fixed wireless technology, didn’t fly high for long after going public via SPAC in early 2022 at an initial $1.8 Last August, Starry emerged from Chapter 11 with restructured finances and a focus on five markets: Boston, New York City, Los Angeles, Washington, D.C.,

Airlines 86

Airlines Wireless Internet Company 86